HYPR

Hyperfine, Inc.

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Hyperfine, Inc. (HYPR) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (C-). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
B-
Factor Score 3.0 / 5.0
Profitability
C+
Factor Score 2.7 / 5.0
Momentum
C-
Factor Score 2.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -2.4
EV / EBITDA -1.7
Rev Growth YoY 73.4%
Gross Margin 52.6%
Price Return 3M -20.4%
Price Return 12M -31.0%
Catalyst Signal 0.00
Market Cap $75.4M
TTM Revenue $19.1M
Price / Sales 4.0
ROE -101.7%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B- (3.0) B- (3.0) C+ (2.7) C- (2.0) C+ (2.6) C+ (2.7)
2026-11-05 B- (3.0) C+ (2.8) C+ (2.7) D+ (1.8) C+ (2.7) C+ (2.6)
2026-10-29 B- (3.0) C+ (2.7) C+ (2.7) D+ (1.8) C+ (2.7) C+ (2.6)
2026-10-22 B- (3.0) C+ (2.7) C+ (2.7) D+ (1.6) C+ (2.6) C+ (2.5)
2026-10-15 B- (3.0) C+ (2.7) C+ (2.7) D+ (1.7) C+ (2.6) C+ (2.6)
Page 1 of 3